Spectrum Pharmaceuticals has selected PharmaVigilant’s I-Vault as its electronic Trial Master File (TMF) Platform. Spectrum, a pharmaceutical company focused on oncology drugs, will standardize on the PharmaVigilant solution.

“We are excited that Spectrum has chosen to use the I-Vault solution to start new electronic trial master files,” said James DeSanti, founder and chief executive officer of PharmaVigilant. “This implementation will automate monitoring of their TMF documentation and will provide Spectrum with an on-demand ‘dashboard’ view of their entire TMF inventory.”